About Primary Immunodeficiency

Overview
Primary immunodeficiency refers to a group of rare disorders that are inherited and characterized by a reduced or absent function of the immune system. The immune system is responsible for protecting the body against infections and diseases. In primary immunodeficiency, there is a defect in either the innate immune system (which provides the initial defense against pathogens) or the adaptive immune system (which develops specific responses to pathogens). This defect makes individuals with primary immunodeficiency more susceptible to infections, which can be recurrent, severe, and difficult to treat. There are over 400 genetically defined single-gene errors of immunity that can cause PID. The prevalence of primary immunodeficiency is estimated to be around 29.1-50.5 individuals per 100,000 people globally. While advances in diagnosis and management have improved outcomes for many patients with primary immunodeficiency, living with a chronic condition can still pose challenges and impact various aspects of an individual's life, including physical, psychological, social, and emotional well-being.
Causes and Risk Factors

Primary immunodeficiency is usually caused by inherited gene mutations that affect the immune system's ability to function properly. Individuals with a family history of primary immunodeficiency have a higher risk of developing the disorder themselves.

As an inherited condition, there are no modifiable risk factors.

Symptoms

The main symptom primary immunodeficiency is recurrent infections. People with primary immunodeficiency often experience frequent and persistent infections, such as respiratory tract infections, sinusitis, bronchitis, ear infections, and pneumonia.

Other symptoms of primary immunodeficiency (PI) include:

  • Allergies: Some individuals with PI may develop allergies, such as allergic rhinitis (hay fever), asthma, or eczema.
  • Autoimmunity: PI can also lead to autoimmune disorders, where the immune system mistakenly attacks the body's own tissues and organs. Examples include autoimmune cytopenia (low blood cell counts), rheumatoid arthritis, or autoimmune thyroid disease.
  • Inflammatory complications: Inflammatory conditions like granulomatous lymphocytic interstitial lung disease (GLILD) or liver regenerative nodular hyperplasia (LRNH) may occur in some individuals with PI.
  • Increased risk of malignancy: Certain types of PI are associated with a higher risk of developing cancer, particularly gastric cancer and lymphoma.
  • Lymphoproliferation: Some individuals with PI may experience abnormal growth of lymphocytes, leading to lymphoproliferative disorders.
  • Enteropathy: Digestive system problems like enteropathy or gastrointestinal inflammation can occur in some cases.

It's important to note that the symptoms and severity of PI can vary widely among individuals. If you suspect you have PID or are experiencing any concerning symptoms, it is recommended to consult with a healthcare professional for proper evaluation and diagnosis.

Diagnosis

To diagnose primary immunodeficiency (PI), several examinations, tests, and procedures are commonly performed:

  • Medical history: The healthcare professional will gather information about your medical history, including frequency and types of infections and family history of relatives with inherited immune system disorders.
  • Laboratory tests: These may include blood tests to check for immunoglobulin levels, immune system blood cells, antibody responses, and B-cell enumeration. Other samples like urine or body tissues may also be tested.

Additional examinations, tests, and procedures may be performed based on initial findings or individual factors. These may include:

  • Genetic testing: This can identify specific gene mutations associated with PI.
  • Functional assays: These tests evaluate the immune system's ability to respond to infections and determine its overall function.
  • Flow cytometry: This technique helps analyze different types of immune cells in the blood.
  • Pathogen screening: Tests like nucleic acid detection and bacterial culture can identify specific pathogens causing infections.

It's important to consult with your healthcare provider who can recommend the most appropriate examinations, tests, and procedures based on your individual situation.

Treatment Options

The goals of treatment for primary immunodeficiency (PI) are to improve health-related quality of life (HRQoL) and reduce the burden of disease. To achieve these goals, the following treatment options may be recommended:

  • Immunoglobulin (Ig) Replacement Therapy: Most patients with PI require lifelong Ig replacement therapy. This treatment involves administering immunoglobulins (antibodies) to replace the missing or deficient ones in the immune system. Ig therapy helps reduce the rate of infections, related hospitalizations, and improves HRQoL.
  • Switching from Intravenous (IVIG) to Subcutaneous Immunoglobulins (SCIG): Some patients may switch from IVIG to SCIG, which involves self-administering immunoglobulins under the skin. This switch can provide convenience and flexibility while maintaining therapeutic efficacy.

It is important to note that specific medication types or therapies may vary based on individual needs and should be discussed with a healthcare professional. Medication dosing may be affected by many factors, so it is essential to consult a healthcare professional for personalized advice. Side effects can occur, so it's important to check with a healthcare professional or read the information provided with your medication for side effect information.